Skip to Main Content

2,015

Views

0

CrossRef citations to date

0

Altmetric

Oncology

Budget impact analysis of comprehensive genomic profiling for untreated advanced or recurrent solid cancers in Japan

Wentao Tanga Chugai Pharmaceutical Co., Ltd, Tokyo, JapanView further author information

,

Keigo Hanadab Crecon Medical Assessment Co., Ltd, Tokyo, JapanView further author information

,

Yoshiharu Motooc Komatsu Sophia Hospital, Komatsu, Japan

https://orcid.org/0000-0002-0776-6434 View further author information

,

Hiroyuki Sakamakid School of Health Innovation, Kanagawa University of Human Services, Kawasaki, JapanView further author information

,

Takaaki Odaa Chugai Pharmaceutical Co., Ltd, Tokyo, JapanView further author information

,

Kazuyuki Furutaa Chugai Pharmaceutical Co., Ltd, Tokyo, JapanView further author information

,

Hikaru Abutania Chugai Pharmaceutical Co., Ltd, Tokyo, JapanView further author information

,

Satoru Itoa Chugai Pharmaceutical Co., Ltd, Tokyo, JapanCorrespondence[email protected]
View further author information

&

Kiichiro Tsutanie Division of Health Sciences, Tokyo Ariake University of Medical and Health Sciences, Tokyo, JapanView further author information